Part Number : NDC00173-0363-00 | Manufacturer : Glaxowellcome | ||
NSN : 6505-01-285-9011 (6505012859011) | |||
Item Name : Ranitidine Injection Usp | CAGE Code : 34006 | ||
NIIN : 01-285-9011 (012859011) | |||
INC Code : 45817 | |||
NCB Code : 01 | Country : USA | ||
Alternate P/N: NDC00173036300 |
Thank you for taking an interest in part number NDC00173-0363-00, that of which is listed with the description Ranitidine Injection Usp; Manufactured by Glaxowellcome and listed alongside the NSN 6505012859011, part number NDC00173-0363-00 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
Part Number : NDC00173-0363-00 | Manufacturer : Glaxowellcome | ||
NSN Number : 6505-01-285-9011 (6505012859011) | |||
Item Name : Ranitidine Injection Usp | CAGE Code : 34006 | ||
NIIN : 012859011 |
Thank you for taking an interest in part number NDC00173-0363-00, that of which is listed with the description Ranitidine Injection Usp; Manufactured by Glaxowellcome and listed alongside the NSN 6505012859011, part number NDC00173-0363-00 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
---|---|---|---|---|---|---|
6505-01-285-9011 Item Description: Ranitidine Injection Usp | 6505 | 012859011 | M | Y | ||
CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
U | A | |||||
Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
Ndc00173-0363-00 | 5 | 2 | 3 |
MRC | Criteria | Characteristic |
---|---|---|
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 25.000 MILLIGRAMS RANITIDINE PER MILLILITER |
CQCT | PRIMARY CONTAINER TYPE | VIAL, MULTIPLE DOSE |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 40.000 MILLILITERS |
CSGS | ADMINISTRATION | INTRAVENOUS OR INTRAMUSCULAR |
CXCY | III PART NAME ASSIGNED BY CONTROLLING AGENCY | RANITIDINE INJECTION USP 25MG/ML 40ML VIAL |
MDES | MEDICAL DESIGNATION | UNITED STATES PHARMACOPEIA |
We hope that you will visit us again the next time you need board-level components, aviation and aerospace parts, and more. Allow us to serve as your strategic purchasing partner.
Request for Quote